Drug
Abbv 101
Abbv 101: highest development phase Phase 1, developed by AbbVie. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- AbbVie
Trials
| Drug | Phase | Indication |
|---|---|---|
| ABBV-101 NCT05753501 | Phase 1 | Hematologic Cancer |
Latest
No recent events.
Follow Abbv 101 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.